Our Pricing

How to Calculate Your Wegovy Dose by Clicks Online

Understanding how to calculate wegovy dose by clicks uk correctly ensures you receive the precise semaglutide amount prescribed by your clinician. Each Wegovy pen delivers a pre-set dose per injection, but knowing the click mechanism helps you confidently self-administer this once-weekly weight loss treatment. At Cured Pharmacy, Wegovy is available from £79.00 with full dosing guidance included with every prescription.

Understanding the Wegovy Pen Click System

Wegovy pens are pre-filled, single-dose injectors designed for subcutaneous administration once weekly [1]. Unlike multi-dose pens that require manual dose selection, each Wegovy pen contains one fixed dose of semaglutide that delivers automatically when you press the injection button fully until you hear a click.

The click you hear confirms the injection mechanism has engaged and the full dose is being delivered. You must hold the pen against your skin for approximately 6 seconds after the click to ensure complete delivery [1]. The dose counter window will show '0' when the injection is complete, and a yellow bar will appear in the window.

Each pen strength is colour-coded and clearly labelled with the dose amount: 0.25mg (grey cap), 0.5mg (yellow cap), 1mg (light blue cap), 1.7mg (blue cap), and 2.4mg (dark blue cap). Your prescriber will specify which strength pen to use based on your current stage in the dose escalation schedule [2].

Wegovy Dosing Schedule: Week-by-Week Escalation

Wegovy follows a structured dose escalation protocol designed to minimise gastrointestinal side effects whilst optimising weight loss outcomes [2]. The gradual increase allows your body to adapt to semaglutide's effects on gastric emptying and appetite regulation.

The standard UK-licensed escalation schedule begins with 0.25mg once weekly for 4 weeks, followed by 0.5mg for 4 weeks, then 1mg for 4 weeks, 1.7mg for 4 weeks, and finally the maintenance dose of 2.4mg weekly [2]. Each transition occurs after completing a full 4-week cycle at the previous dose.

In the STEP clinical trial programme, participants following this escalation achieved an average 14.9% body weight reduction over 68 weeks, with the maintenance dose of 2.4mg producing the greatest effect [2]. Your UK prescriber may adjust the schedule based on your tolerance and clinical response.

When to Delay Dose Escalation

If you experience persistent nausea, vomiting, or diarrhoea at your current dose, your prescriber may recommend remaining at that strength for an additional 4 weeks before escalating [1]. This individualised approach maintains treatment adherence whilst managing side effects effectively. Never adjust your dose without consulting your prescriber, as the escalation schedule is clinically validated for both safety and efficacy.

Step-by-Step Wegovy Injection Instructions

Before each injection, inspect the Wegovy pen to ensure the liquid is clear and colourless. Check the dose counter shows the correct dose number and that the pen has not been previously used [1]. Select an injection site on your abdomen, thigh, or upper arm, rotating sites weekly to prevent lipodystrophy.

Remove the pen cap and place the pen perpendicular to your skin without angling. Press the injection button firmly until it clicks, then continue holding the pen against your skin whilst counting slowly to 6 [1]. You'll feel the button depress fully, and the dose counter will move to '0' with a yellow bar appearing in the window.

After 6 seconds, withdraw the pen and check the dose counter confirms '0'. A drop of liquid may appear at the needle tip—this is normal and does not affect your dose. Dispose of the used pen immediately in a sharps container. The entire pen is single-use and cannot be refilled or reused [1].

Common Injection Mistakes to Avoid

The most frequent error is removing the pen too quickly before the full 6-second delivery completes, resulting in an incomplete dose. Other mistakes include injecting through clothing, reusing injection sites consecutively, or attempting to use a pen that has been frozen or exposed to temperatures above 30°C [1]. Always store unused pens in the refrigerator between 2-8°C and allow them to reach room temperature before injecting.

Calculate Wegovy Dose by Clicks: Troubleshooting Guide

If your pen does not click when you press the injection button, first confirm you have removed the pen cap fully and the dose counter shows the expected dose number. The pen will not activate if it has been previously used or if the needle is blocked [1].

Should the dose counter not move to '0' after injection, or if no yellow bar appears, the full dose may not have been delivered. Do not attempt a second injection immediately. Contact your prescriber or Cured Pharmacy's clinical team on (+44) 116 4646009 for guidance, as administering a duplicate dose could cause hypoglycaemia or severe nausea.

Pen malfunctions are rare but can occur if the device has been dropped, frozen, or stored incorrectly. Always inspect your pen before use and store it according to manufacturer guidelines. If you receive a faulty pen, our pharmacy team will arrange an immediate replacement at no additional cost.

Wegovy vs Other Semaglutide Weight Loss Treatments

Wegovy contains the same active ingredient—semaglutide—as other GLP-1 receptor agonists but is specifically licensed for chronic weight management at higher doses than those used for type 2 diabetes [2]. The 2.4mg maintenance dose is approximately double the maximum dose used in diabetes formulations.

Clinical trials demonstrate Wegovy's superior weight loss outcomes compared to older injectable treatments. The STEP 1 trial showed participants achieved 14.9% average weight reduction with Wegovy versus 2.4% with placebo over 68 weeks [2]. This magnitude of effect exceeds that seen with daily injectable alternatives, which typically produce 5-9% weight loss.

The once-weekly administration offers significant convenience advantages over daily injections, improving long-term adherence. In our clinical experience at Cured Pharmacy, patients report greater treatment satisfaction with weekly dosing, particularly those balancing work and family commitments.

Choosing Between Wegovy and Alternative Weight Loss Treatments

Your UK prescriber will consider your medical history, weight loss goals, previous treatment responses, and personal preferences when recommending between available options. Factors such as injection frequency, side effect profiles, contraindications, and cost all influence the most appropriate choice. All prescription weight loss medications available through Cured Pharmacy require clinical assessment by a UK-registered prescriber to ensure safe, effective treatment.

Managing Side Effects and Optimising Wegovy Results

The most common side effects of Wegovy are gastrointestinal: nausea (44% of participants), diarrhoea (30%), vomiting (24%), and constipation (24%) in clinical trials [2]. These effects typically diminish over 4-8 weeks as your body adapts to each dose level.

To minimise nausea, eat smaller, more frequent meals rather than large portions, avoid high-fat foods, and stay well-hydrated throughout the day. Injecting Wegovy in the evening rather than morning may help if nausea interferes with daytime activities. If symptoms persist beyond 2 weeks at a given dose, consult your prescriber about temporarily remaining at your current strength.

Wegovy works most effectively when combined with a reduced-calorie diet and increased physical activity [2]. In the STEP trials, participants received lifestyle counselling alongside medication, contributing to the substantial weight loss achieved. Our clinical team at Cured Pharmacy provides ongoing support and practical guidance throughout your treatment journey, helping you implement sustainable dietary and activity changes.

Scientific References

1. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799
2. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.